Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Biomarker-Guided strategy aims to slow kidney decline in CKD patients

NCT ID NCT07239570

First seen Nov 20, 2025 · Last updated May 23, 2026 · Updated 26 times

Summary

This study tests whether using specific biomarkers to guide treatment choices can better slow the loss of kidney function in people with chronic kidney disease (CKD) compared to standard care. About 125 adults with CKD and elevated protein in their urine will receive either a tailored treatment plan or usual care. The goal is to see if the personalized approach reduces the rate of kidney decline over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Clinico de Valencia

    NOT_YET_RECRUITING

    Valencia, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Lund University

    NOT_YET_RECRUITING

    Malmö, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Steno Diabetes Center Copenhagen

    RECRUITING

    Herlev, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Medical Center Hamburg-Eppendorf

    NOT_YET_RECRUITING

    Hamburg, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.